Accolade To Present at Piper Sandler 35th Annual Healthcare Conference

2 years ago

SEATTLE, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced…

Appeals Court Upholds PTAB’s Finding of Invalidity of Purdue’s 961 Patent

2 years ago

STOUGHTON, Mass., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company, today…

DLH to Announce Fiscal 2023 Fourth Quarter Financial Results

2 years ago

ATLANTA, Nov. 27, 2023 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading healthcare and…

Philips improves workflow and efficiency with next generation ultrasound systems EPIQ Elite and Affiniti at #RSNA23

2 years ago

Clinician using next generation EPIQ Elite VM10 with a patient Remote collaboration ultrasound EPIQ Elite VM10 November 27, 2023 Improved…

Aclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan Exams

2 years ago

Pace of Nociscan orders accelerated 2.5x for the last 250 scans compared to the first 250 scans Further acceleration of…

Spectral AI Appoints Erich Spangenberg as Chairman of the Executive Committee of the Board of Directors

2 years ago

DALLAS, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence…

iCAD’s ProFound AI Can Predict 1-2 Year Risk for Breast Cancer and Reveal Insights for Heart Disease

2 years ago

New research presented at Radiological Society of North America annual meeting confirms ability of ProFound Breast Health Suite to predict…

Ocuphire Pharma Announces Appointment of Joseph Schachle, M.B.A., as Chief Operating Officer

2 years ago

Mr. Schachle Brings Over 30 Years of Experience in Biotech and Pharma with Expertise Across Multiple Functional Areas Including Corporate…

Cocrystal Pharma to Present at the NobleCon 19 Conference on December 4, 2023

2 years ago

BOTHELL, Wash., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that James…

Vor Bio to Participate in the JMP Securities Hematology and Oncology Summit

2 years ago

CAMBRIDGE, Mass., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today…